Medical News

RSS

Heritage announces availability of Prochlorperazine Edisylate Injection

Heritage Pharmaceuticals Inc. announced the immediate availability of Prochlorperazine Edisylate Injection in the 5mg/mL strength.

16 Jan 2014

FDA-regulated study investigates use of child's stem cells for acquired sensorineural hearing loss

Cord Blood Registry, the world's largest and most experienced newborn stem cell company, announces the start of a U.S. Food and Drug-regulated study being conducted at Florida Hospital for Children in Orlando to investigate the use of a child's stem cells from their own stored umbilical cord blood as a treatment for acquired sensorineural hearing loss.

16 Jan 2014

Economic crisis worsens mental health problems in men

Experts and social organizations have warned of the negative effects that the economic crisis could mean for the health of the population. But it was not easy to demonstrate with data what is happening. A new comparative analysis of the last two National Health Surveys revealed a rise in mental health problems in men (from 15% in 2006 to 17% in 2012), which contrasts on the other hand with a decrease in women (25% in 2006 to 23% in 2012).

16 Jan 2014

New research shows promise in helping combat novel drug-resistant H7N9 influenza virus

The novel avian H7N9 influenza virus has caused more than 130 human infections with 43 deaths in China. New research, conducted under the supervision of Kansas State University's Juergen Richt, is showing promise in helping to fight this deadly virus.

16 Jan 2014

American Diabetes Association receives $5M grant for Pathway to Stop Diabetes program

AstraZeneca and Bristol-Myers Squibb Company today announced that the companies' U.S. Diabetes Alliance is providing a three-year grant to the American Diabetes Association's Pathway to Stop Diabetes program. The innovative research initiative provides resources and support for a new generation of diabetes researchers and is designed to generate exciting discoveries through excellence, innovation, collaboration and radical thinking.

16 Jan 2014

Biothera enhances innate immune responses to Imprime PGG drug candidate

Biothera has enhanced innate immune responses to its cancer immunotherapy drug candidate Imprime PGG in subjects regardless of biomarker status, demonstrating the opportunity to treat a larger patient population. The in vitro research will be presented today at the Cambridge Healthtech Institute's Antibody-Drug Conjugates/Engineering Targeted Therapeutics conference in Palm Springs, CA.

16 Jan 2014

RegionalCare Hospital Partners deploys AirStrip solutions at hospitals across the country

RegionalCare Hospital Partners, a privately-owned system of regionally-focused community hospitals, has chosen AirStrip - the leading provider of mobile healthcare applications that drive clinical transformation - to be its standard for clinical mobility solutions at their hospitals across the country.

16 Jan 2014

Prostate cancer vaccines receive a boost in funding

The development of two innovative new vaccines that are hoped to offer an alternative to castration therapy for men with recurring prostate cancer, is due for an $8 million boost in funding.

16 Jan 2014

New initiatives launched to improve workplace mental health across Canada

The Mental Health Commission of Canada, along with its partners, CSA Group and Bureau de normalisation du Québec, joined Labour Minister Dr. K. Kellie Leitch alongside business and labour leaders today to announce new initiatives to improve workplace mental health across Canada.

16 Jan 2014

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has completed the sale of Aqua Pharmaceuticals Holdings, Inc. to Almirall S.A. for up to $402.6 million in cash

16 Jan 2014

Theravent honored with GOOD DESIGN Award for snoring therapy

Theravent, Inc., a medical device company providing noninvasive solutions for people with sleep disordered breathing, has been honored with a GOOD DESIGN Award in the medical category for the design of its product, Theravent Advanced Nightly Snore Therapy.

16 Jan 2014

New discovery has potential to transform heart attack treatments

An Australian discovery has the potential to transform the treatment of a heart attack, after a new approach boosted heart function and reduced heart scarring in preclinical studies.

16 Jan 2014

Crozer-Keystone Health System wins 2013 Foster G. McGaw Prize for Excellence in Community Service

In honor of its broad-based efforts to improve the lives of the most vulnerable members of its community, Crozer-Keystone Health System in Delaware County, Pa. is the recipient of the 2013 Foster G. McGaw Prize for Excellence in Community Service, one of the most esteemed community service honors in healthcare.

From Baxter International Inc. 16 Jan 2014

Transgenomic, Horizon Discovery collaborate to develop improved genetic diagnostic tests with state of art controls

Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, and Horizon Discovery Ltd. (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced they have entered into a collaboration agreement to develop improved genetic diagnostic tests incorporating state of the art controls.

16 Jan 2014

Parental leave policies tend to reduce physical and mental stress levels in women

Government policies that allow both parents to take time off after a child is born provide positive benefits for the physical and mental health of women, according to a literature review that looked at the influence of public policies on women's overall health.

16 Jan 2014

FTM transgender patients are more likely to have inadequate Pap tests

A new study finds that female-to-male (FTM) transgender patients had over 10 times higher odds of having an inadequate Papanicolaou (Pap) test compared to female patients.

16 Jan 2014

Monitoring individuals with chronic HBV is cost-effective strategy for China

A novel study determined that monitoring inactive chronic hepatitis B (HBV) carriers is a cost-effective strategy for China. However, results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that increasing treatment, monitoring and adherence to therapy are necessary to achieve significant health benefits at the population level.

16 Jan 2014

Atlas develops ultra-rapid point-of-care tests for a range of infectious diseases

Atlas Genetics Ltd, the diagnostic company developing ultra-rapid point-of-care (POC) tests for a range of infectious diseases, today announces that it has completed development of the Atlas io™ Reader, a POC device that can deliver laboratory quality results for molecular assays in under thirty minutes.

16 Jan 2014

US underestimated its progress in war on cancer, say Dartmouth researchers

Since the enactment of the National Cancer Act in 1971, the U.S. has spent hundreds of billions of dollars in cancer research and treatment. And yet, the cancer mortality rate-the historic benchmark of progress-has only declined modestly while the mortality rates of other leading causes of death have declined substantially. This difference has led many to question whether we've made progress in the 'War on Cancer'. The answer is definitively yes according to Norris Cotton Cancer Center research published Monday in the Journal of Clinical Oncology.

16 Jan 2014

Study shows direct link between metabolism in brain cells and ability to signal information

A new study by scientists at McGill University and the University of Zurich shows a direct link between metabolism in brain cells and their ability to signal information. The research may explain why the seizures of many epilepsy patients can be controlled by a specially formulated diet.

16 Jan 2014

Medical News

Heritage announces availability of Prochlorperazine Edisylate Injection

FDA-regulated study investigates use of child's stem cells for acquired sensorineural hearing loss

Economic crisis worsens mental health problems in men

New research shows promise in helping combat novel drug-resistant H7N9 influenza virus

American Diabetes Association receives $5M grant for Pathway to Stop Diabetes program

Biothera enhances innate immune responses to Imprime PGG drug candidate

RegionalCare Hospital Partners deploys AirStrip solutions at hospitals across the country

Prostate cancer vaccines receive a boost in funding

New initiatives launched to improve workplace mental health across Canada

RoundTable Healthcare Partners sells Aqua Pharmaceuticals Holdings for $402.6M to Almirall

Theravent honored with GOOD DESIGN Award for snoring therapy

New discovery has potential to transform heart attack treatments

Crozer-Keystone Health System wins 2013 Foster G. McGaw Prize for Excellence in Community Service

Transgenomic, Horizon Discovery collaborate to develop improved genetic diagnostic tests with state of art controls

Parental leave policies tend to reduce physical and mental stress levels in women

FTM transgender patients are more likely to have inadequate Pap tests

Monitoring individuals with chronic HBV is cost-effective strategy for China

Atlas develops ultra-rapid point-of-care tests for a range of infectious diseases

US underestimated its progress in war on cancer, say Dartmouth researchers

Study shows direct link between metabolism in brain cells and ability to signal information

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News